Keywords: xencor, enters, ab, optimization, deal, boeh, ingel

Xencor enters Ab optimization deal with Boeh Ingel

Article | 19 February 2007

US group Xencor, a developer of protein and antibody-based therapeutics, has entered into a collaboration with German privately-owned drugmaker Boehringer ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Boehringer Ingelheim

Go to company listing